Tata Chemicals is currently trading at Rs. 438.40, up by 1.05 points or 0.24% from its previous closing of Rs. 437.35 on the BSE.
The scrip opened at Rs. 443.90 and has touched a high and low of Rs. 443.90 and Rs. 437.55 respectively. So far 15833 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 460.00 on 05-Dec-2014 and a 52 week low of Rs. 244.80 on 28-Jan-2014.
Last one week high and low of the scrip stood at Rs. 441.30 and Rs. 419.25 respectively. The current market cap of the company is Rs. 11220.74 crore.
The promoters holding in the company stood at 31.06 % while Institutions and Non-Institutions held 46.43 % and 22.51 % respectively.
Tata Chemicals, which is set to launch the Rs 50-crore nutraceuticals manufacturing facility shortly, is planning to introduce retail products in this category in future. The plant initially will have a capacity of 300 tonnes annually and would scale up to 1,000 tonnes.
Nutraceuticals is estimated to become $4 billion market in India by 2018. The company was focusing at making oligosaccharides, sweeteners, anti-obesity products through green routes. The company will commission a pilot plant to make nutraceuticals in Chennai as part of focus on speciality and consumer products businesses. After branded salt, pulses (dal) under iSakthi brand, the company entered masalas in Punjab recently.
Tata Chemicals is the world’s second largest producer of soda ash with manufacturing facilities in Asia, Europe, Africa and North America. The company’s industry essentials product range provides key ingredients to some of the world’s largest manufacturers of glass, detergents and other industrial products.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: